MB Daily: Headlines and Analysts’ Updates for 11/29/2016


Ratings changes for Nivalis Therapeutics, Merrimack Pharmaceuticals, Nivalis Therapeutics, United Therapeutics Corp., Ariad Pharmaceuticals, Blueprint Medicines Corp., BioMarin Pharmaceutical and more…Be sure to add MarketBeat.com to your safe-sender list or address book to ensure your newsletter gets delivered to your inbox. Click Here to Learn How.

MarketBeat.com Daily Update: Analysts' Upgrades, Downgrades & New Coverage Facebook  Twitter  StockTwits
Upgrade to MarketBeat Daily Premium and get early delivery (9:00 AM ET), additional ratings data, broker performance ratings, email and SMS alerts, earnings announcements, dividend declarations, insider trades and personalized news and headlines for stocks on your watchlist. Click Here to Start Your 30-Day Risk-Free Trial. November, 29 2016
Here are today’s top stories and analysts’ upgrades, downgrades and new coverage brought to you by MarketBeat.com:

Top Stories

If you would like to unsubscribe or change which emails you receive, Manage Your Mailing Preferences or Unsubscribe.

If you have questions about your subscription, feel free to contact us via email at contact@marketbeat.com.

This message may contain commercial elements (such as advertising) and was sent on behalf of MarketBeat.com, a division of American Consumer News, LLC.
© 2006-2016 American Consumer News, LLC. All Rights Reserved.
1401 S. Discovery Ave., Sioux Falls, SD 57106. United States.